Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Kendle 4Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Kendle 4Q

Service revenues in the quarter were $109 million (+5%) and $475.1 million for the year (+19%). New business awards totaled $163 million in the quarter and $759 million for the year.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kendle

4Q Revenues: $161.3 million (+4%)

4Q Earnings: $5.0 million (-22%)

FY Revenues: $678.6 million (+19%)

FY Earnings: $29.4 million (+57%)

Comments: Service revenues in the quarter were $109 million (+5%) and $475.1 million for the year (+19%). New business awards totaled $163 million in the quarter and $759 million for the year. Total business authorizations at Dec. 31, 2008, were $1.0 billion (+18%). Early stage service revenues were $9.7 million in the quarter (+70%) and $35.2 million for the year (+64%). Late stage service revenues were $98.5 million in the quarter (+4%) and $430.3 million for the year (+17%). North America revenues were up 52% in the quarter and 48% for the year. Revenues in Europe were up 36% in the quarter and 40% for the year. Latin America revenues were up 9% in the quarter and 8% for the year. Asia-Pacific revenues were up 3% in the quarter and 4% for the year. The company incurred additional costs in the quarter related to a programming issue for a study for one customer. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters